Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

CDC probes lung illnesses linked to e-cigarette use

Published 08/18/2019, 09:28 PM
Updated 08/18/2019, 09:28 PM
© Reuters. FILE PHOTO: A man vapes outside an office block in Manchester, Britain

© Reuters. FILE PHOTO: A man vapes outside an office block in Manchester, Britain

By April Joyner

NEW YORK (Reuters) - The U.S. Centers for Disease Control and Prevention is investigating a "cluster" of lung illnesses that it believes may be linked to e-cigarette use after such cases were reported in 14 states.

The CDC said there was no evidence that an infectious disease was behind the illnesses and that more information was needed to determine whether they were in fact caused by e-cigarette use.

The CDC is working with health departments in Wisconsin, Illinois, California, Indiana and Minnesota on the investigation. Since June 28, states have reported 94 possible cases of severe lung illness tied to vaping, primarily among teenagers and young adults, according to a CDC statement on Saturday. Of those cases, 30 occurred in Wisconsin.

Patients experienced coughing, shortness of breath and fatigue. Some had serious breathing difficulties that required ventilation.

A CDC spokesman was unable to provide additional information on the investigation. Representatives for the state health departments did not respond to inquiries.

Other states, including New York and New Jersey, have also issued health advisories regarding vaping-linked lung illnesses.

The CDC did not link the illnesses to any specific product. In the United States, Juul Labs, in which Altria Group Inc (N:MO) has a 35% stake, is the dominant e-cigarette maker.

"Like any health-related events reportedly associated with the use of vapor products, we are monitoring these reports," Juul Labs said on Sunday in a statement emailed to Reuters.

"These reports reaffirm the need to keep all tobacco and nicotine products out of the hands of youth through significant regulation on access and enforcement. We also must ensure illegal products, such as counterfeit, copycat, and those that deliver controlled substances, stay out of the market and away from youth."

Juul also noted that, according to some media reports, several incidences of lung illness linked to vaping have involved THC, found in marijuana, "a Schedule 1, controlled substance that we do not sell," the company said.

© Reuters. FILE PHOTO: A man vapes outside an office block in Manchester, Britain

E-cigarettes are generally thought to be safer than traditional cigarettes, which kill up to half of all lifetime users, according to the World Health Organization. But the long-term health effects of the nicotine devices remain largely unknown. In April, the U.S. Food and Drug Administration began an investigation into seizures among e-cigarette users.

Latest comments

The number of smokers went down decades in a row but the number of lung cancer and heart disease not, as it had been promised.Liers.
I dont have nicotine much at all in my e-cig. I get to have smoke breaks at work.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.